Anna Dayer-Jankechova1,2, Pierre Fournier1, Pierre Allemann1, Michel Suter3,4. 1. Department of Visceral Surgery, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. 2. Department of Surgery, Hôpital Riviera-Chablais (HDC), 1860, Aigle-Monthey, Switzerland. 3. Department of Visceral Surgery, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. michelsuter@netplus.ch. 4. Department of Surgery, Hôpital Riviera-Chablais (HDC), 1860, Aigle-Monthey, Switzerland. michelsuter@netplus.ch.
Abstract
BACKGROUND: Roux-en-Y gastric bypass (RYGBP), one of the commonest performed bariatric procedures, remains a technically challenging operation associated with significant morbidity in high-risk patients. This study was conducted in order to identify predictors of complications after laparoscopic RYGBP. METHODS: Our prospectively established database has been assessed to review 30-day and in-hospital complications graded according to a validated scoring system (Clavien-Dindo) and separated into minor (Clavien-Dindo I-IIIa) and major (Clavien-Dindo IIIb-IV) complications. Patient- and procedure-related factors were analyzed using univariate analysis. Significant factors associated with morbidity were introduced into a multivariate analysis to identify independent predictors. RESULTS: Between 1999 and 2012, 1573 patients underwent laparoscopic RYGBP, 374 male and 1199 female. Mean age was 41 years, and mean body mass index (BMI) was 44.5 kg/m(2). One hundred fifty-nine procedures were reoperations. One hundred fifty (9.5 %) patients developed at least one complication, and 43 (2.7 %) had major complications, leading to death in one case (0.06 %). Risk factors for morbidity were male gender (p = 0.006) and overall experience of the team (p < 0.0001). Prolonged 3-day antibiotic therapy was associated with significantly reduced overall (p < 0.0001) and major (p = 0.005) complication rates. Major complications were associated with smoking (p = 0.016). CONCLUSIONS: The most significant individual risk factors for early complications after RYGBP are male gender, limited surgical experience, and single dose of antibiotics. RYGBP should be performed by experienced teams. Smoking should be discontinued before surgery. Prolonged antibiotic therapy could be considered, especially if a circular stapled gastrojejunostomy is performed with the anvil introduced transorally.
BACKGROUND: Roux-en-Y gastric bypass (RYGBP), one of the commonest performed bariatric procedures, remains a technically challenging operation associated with significant morbidity in high-risk patients. This study was conducted in order to identify predictors of complications after laparoscopic RYGBP. METHODS: Our prospectively established database has been assessed to review 30-day and in-hospital complications graded according to a validated scoring system (Clavien-Dindo) and separated into minor (Clavien-Dindo I-IIIa) and major (Clavien-Dindo IIIb-IV) complications. Patient- and procedure-related factors were analyzed using univariate analysis. Significant factors associated with morbidity were introduced into a multivariate analysis to identify independent predictors. RESULTS: Between 1999 and 2012, 1573 patients underwent laparoscopic RYGBP, 374 male and 1199 female. Mean age was 41 years, and mean body mass index (BMI) was 44.5 kg/m(2). One hundred fifty-nine procedures were reoperations. One hundred fifty (9.5 %) patients developed at least one complication, and 43 (2.7 %) had major complications, leading to death in one case (0.06 %). Risk factors for morbidity were male gender (p = 0.006) and overall experience of the team (p < 0.0001). Prolonged 3-day antibiotic therapy was associated with significantly reduced overall (p < 0.0001) and major (p = 0.005) complication rates. Major complications were associated with smoking (p = 0.016). CONCLUSIONS: The most significant individual risk factors for early complications after RYGBP are male gender, limited surgical experience, and single dose of antibiotics. RYGBP should be performed by experienced teams. Smoking should be discontinued before surgery. Prolonged antibiotic therapy could be considered, especially if a circular stapled gastrojejunostomy is performed with the anvil introduced transorally.
Authors: Jonathan F Finks; Kerry L Kole; Panduranga R Yenumula; Wayne J English; Kevin R Krause; Arthur M Carlin; Jeffrey A Genaw; Mousumi Banerjee; John D Birkmeyer; Nancy J Birkmeyer Journal: Ann Surg Date: 2011-10 Impact factor: 12.969
Authors: Matthew L Maciejewski; Deborah A Winegar; Joel F Farley; Bruce M Wolfe; Eric J DeMaria Journal: Surg Obes Relat Dis Date: 2012-09-11 Impact factor: 4.734
Authors: Raquel Sánchez-Santos; Nuria Vilarrasa; Jorge Pujol; Pablo Moreno; Jose Manuel Francos; Antonio Rafecas; Carlos Masdevall Journal: Obes Surg Date: 2006-04 Impact factor: 4.129
Authors: Guilherme M Campos; Ruxandra Ciovica; Stanley J Rogers; Andrew M Posselt; Eric Vittinghoff; Mark Takata; John P Cello Journal: Arch Surg Date: 2007-10
Authors: Corey J Lager; Nazanene H Esfandiari; Angela R Subauste; Andrew T Kraftson; Morton B Brown; Ruth B Cassidy; Darlene Bellers; Amy L Lockwood; Oliver A Varban; Elif A Oral Journal: Obes Surg Date: 2017-07 Impact factor: 4.129
Authors: Rishi Singhal; Victor Roth Cardoso; Tom Wiggins; Jonathan Super; Christian Ludwig; Georgios V Gkoutos; Kamal Mahawar Journal: Int J Obes (Lond) Date: 2021-12-15 Impact factor: 5.551